Company profile: Enavate Sciences
1.1 - Company Overview
Company description
- Provider of capital and strategic growth support to therapeutic and enabling technology companies, partnering with life sciences companies and their investors to advance and accelerate the development of novel therapies and help companies realize their potential.
Products and services
- Company Building Partnership: Enavate Sciences builds integrated partnerships with life sciences companies and their investors, offering capital and strategic growth support to help companies realize their potential
- Capital Investment: Enavate Sciences delivers institutional-grade capital to therapeutic and enabling technology companies, advancing and accelerating the development of novel therapies through targeted funding aligned with strategic growth priorities
- Strategic Growth Support: Enavate Sciences supplies sector-focused strategic growth support for therapeutic and enabling technology companies, advancing and accelerating the development of novel therapies and helping companies realize their potential
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Enavate Sciences
Vectura
HQ: United Kingdom
Website
- Description: Provider of inhalation drug delivery services; formulation development for inhalers, nebulisers, and nasal sprays; comprehensive pharmaceutical analysis; in-house manufacturing of drug products and medical devices for development studies and clinical trials; device platforms for DPI, pMDI, and nebuliser technologies; and process development and technical transfer for airways-related diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Vectura company profile →
Pearl Pathways
HQ: United States
Website
- Description: Provider of life science product development and life-saving devices, diagnostics, and therapeutic products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pearl Pathways company profile →
Capua BioServices
HQ: Italy
Website
- Description: Provider of CDMO services in microbial fermentation, offering custom microbial process development and manufacturing. Delivers dedicated solutions for proteins, specialty small molecules and microorganisms for applications in pharma, food, feed and other bio-industrial markets.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Capua BioServices company profile →
Abveris
HQ: United States
Website
- Description: Provider of antibody discovery solutions for reagent and therapeutic applications, offering DiversimAb hyperimmune mouse technology for diverse monoclonal antibodies; Beacon single B-cell screening; hybridoma discovery (production, purification, sequencing, recombinant production); antigen production and design; anti-idiotype antibody discovery; and fully human antibodies via humanized mice.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Abveris company profile →
Sterling Pharma Solutions
HQ: United Kingdom
Website
- Description: Provider of small molecule API development and manufacturing services for the global pharmaceutical industry, from pre-clinical to commercial. Offers ADC pre-clinical bioconjugation services with potent cytotoxin handling; PDMO® collaborative API development and integrated project management; hazardous chemistry; high potency and controlled substance API manufacturing; and peptide API development with large-scale chromatography.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sterling Pharma Solutions company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Enavate Sciences
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Enavate Sciences
2.2 - Growth funds investing in similar companies to Enavate Sciences
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Enavate Sciences
4.2 - Public trading comparable groups for Enavate Sciences
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →